Skip to content
10-Q

Quarterly Report

Advanced BioMedical Technologies, Inc.

0001493152-19-014373

← back to feed
Filed
Sep 20, 2019 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2019 · Sep 23, 2019 69.62M sh
Cash And Equivalents Q3 2019 · Jul 31, 2019 $10.88K
Cash And Equivalents Q3 2019 · Oct 31, 2018 $6.86K
Current Liabilities Q3 2019 · Jul 31, 2019 $6.59M
Current Liabilities Q3 2019 · Oct 31, 2018 $5.76M
Current Assets Q3 2019 · Jul 31, 2019 $96.82K
Current Assets Q3 2019 · Oct 31, 2018 $39.51K
Total Assets Q3 2019 · Jul 31, 2019 $218.46K
Total Assets Q3 2019 · Oct 31, 2018 $142.4K
Capex Q3 2019 · Jul 31, 2018 $17.69K
Operating Cash Flow Q3 2019 · Jul 31, 2018 −$601.68K
Stockholders Equity Q3 2019 · Jul 31, 2018 −$5.49M
Stockholders Equity Q3 2019 · Apr 30, 2018 −$5.64M
Stockholders Equity Q3 2019 · Jan 31, 2018 −$5.47M
Stockholders Equity Q3 2019 · Oct 31, 2017 −$5M
Sga Expense Q3 2019 · Jul 31, 2018 $120.8K
Sga Expense Q3 2019 · Jul 31, 2018 $360.77K
Rd Expense Q3 2019 · Jul 31, 2018 $13.17K
Rd Expense Q3 2019 · Jul 31, 2018 $36.89K
Net Income Q3 2019 · Jul 31, 2018 −$215.84K
Net Income Q3 2019 · Jul 31, 2018 −$647.2K
Net Income Q3 2019 · Apr 30, 2018 −$208.82K
Net Income Q3 2019 · Jan 31, 2018 −$222.54K
Operating Income Q3 2019 · Jul 31, 2018 −$136.22K
Operating Income Q3 2019 · Jul 31, 2018 −$404.43K